Objectives This systematic review aimed to describe medication non-adherence among
people living with multimorbidity according to the current literature, and synthesise …

There are nearly 17 million cancer survivors in the United States, including those who are
currently receiving cancer therapy with curative intent and expected to be long-term …

Introduction: Nonadherence to medication is a challenge to effective treatment of many
chronic diseases, including glaucoma, and persists even with interventions aimed at …

Background The use of highly toxic drugs in cancer treatment and supportive care
medications exposes patients to an increased number of drug-related problems (DRPs) …

New approaches to cancer survivorship care must address the rising number of survivors
who need complex care; the need to personalize care to improve health equity; workforce …

In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of
life. With improvements in early diagnosis and treatment, the number of cancer survivors …

Background Diabetes places patients with cancer at an increased risk of infections,
hospitalizations, and mortality. The objective of the current study was to characterize …

Introduction Advances in breast cancer screening and treatment have led to an increasing
number of breast cancer survivors. The objective of this study was to determine the impact of …

Purpose: Many patients with breast cancer are treated for other conditions and experience
polypharmacy with multiple concurrent medications. Our aim was to evaluate polypharmacy …

Simple Summary Previous epidemiological studies have shown that type 2 diabetes may be
associated with an increased risk of several cancer types and cancer-related mortality …